Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.

MLA

Desbois, A. C., et al. “Efficacy of Anti-TNF Alpha in Severe and Refractory Major Vessel Involvement of Behcet’s Disease: A Multicenter Observational Study of 18 Patients.” Clinical Immunology (Orlando, Fla.), vol. 197, Dec. 2018, pp. 54–59. EBSCOhost, https://doi.org/10.1016/j.clim.2018.08.004.

APA

Desbois, A. C., Biard, L., Addimanda, O., Lambert, M., Hachulla, E., Launay, D., Ackermann, F., Pérard, L., Hot, A., Maurier, F., Mausservey, C., Bernard, F., Noel, N., Alric, L., Mirault, T., Cohen, F., Boussouar, S., Resche-Rigon, M., Cacoub, P., & Saadoun, D. (2018). Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet’s disease: A multicenter observational study of 18 patients. Clinical Immunology (Orlando, Fla.), 197, 54–59. https://doi.org/10.1016/j.clim.2018.08.004

Chicago

Desbois, A C, L Biard, O Addimanda, M Lambert, E Hachulla, D Launay, F Ackermann, et al. 2018. “Efficacy of Anti-TNF Alpha in Severe and Refractory Major Vessel Involvement of Behcet’s Disease: A Multicenter Observational Study of 18 Patients.” Clinical Immunology (Orlando, Fla.) 197 (December): 54–59. doi:10.1016/j.clim.2018.08.004.